Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer

Figure 2

CCL23 serum levels and baseline characteristics. Baseline CCL23 levels are unaltered between BTC patients of different tumor localization (a), T-stage (b), M-stage (d), tumor grading (e), or resection status (f). (c) BTC patients with nodal positive disease (N1) have significantly lower CCL23 levels. CCL23 levels are unaltered between male and female patients (g) as well as patients with different ECOG performance status (h).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)